TP53 and neoplasm: Since MDA-MB-231 cells express mutant p53 [47, 48], the downregulation of p53 that we observed by RNA interference-mediated knockdown of CXCR4 may increase cisplatin anti-tumor activity by inducing cell arrest in the G2/M phase.